RxDoctor Payments Data

Derek Magnuson, PA

Medical · Tampa, FLNPI 1124115126

Payments from drug & device makers

$1,006in general payments, 2019–2025

Across 55 payments — averaging $18.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$253
  • Novo Nordisk$161
  • AstraZeneca$160
  • Lilly USA, LLC$126
  • Pfizer$79
  • Amgen$61
  • plus $167 from 6 others

What the payments were for

  • Food & beverage$1,006100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,006 in reported general payments places this provider in the 55th percentile of 2,031 medical providers in Florida.

See all medical providers in Florida

Medicare billing

Part B allowed, 2024
$37,113
Medicare patients
168
Services billed
497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban76$56,029
OzempicSemaglutide32$55,845
JanuviaSitagliptin Phosphate39$40,215
XareltoRivaroxaban35$26,315
JardianceEmpagliflozin24$21,232
Trelegy ElliptaFluticasone/Umeclidin/Vilanter21$16,146
LinzessLinaclotide20$13,692
MounjaroTirzepatide11$11,715
Spiriva HandihalerTiotropium Bromide12$9,172
SymbicortBudesonide/Formoterol Fumarate18$8,675
BrilintaTicagrelor11$4,644
Gabapentin181$3,290
Atorvastatin Calcium279$3,157
Lantus SolostarInsulin Glargine,hum.Rec.Anlog35$3,101
Omeprazole144$2,862

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$79$56,02976 claims
Novo NordiskOzempic$161$55,84532 claims
Johnson & JohnsonXarelto$35$26,31535 claims
Boehringer IngelheimJardiance$253$21,23224 claims
GSKTrelegy Ellipta$32$16,14621 claims
AbbVieLinzess, Synthroid$30$14,81143 claims
AstraZenecaSymbicort, Brilinta$160$13,31929 claims
Lilly USA, LLCMounjaro$126$11,71511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,031 medical providers in Florida.

Other medical in Tampa

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →